GSK expands royalty-free licence to HIV drugs
26 July 2010
Emma Barraclough, London
An HIV drugs company set up by GlaxoSmithKline and Pfizer is to offer generic drugs manufacturers a royalty-free voluntary licence to all its healthcare products
ViiV Healthcare says it will expand the number of countries where people can access generic versions of its antiretroviral medicines to include all least developed countries, all low income countries and all of sub-Saharan Africa. It says this covers 80% of all people living with HIV.
The company, which is 85% owned by GSK with Pfizer owning the rest, says it will also offer generic companies royalty-free voluntary licences for its future products.
The move comes as UNITAID, an international drug purchasing facility that partners with organisations...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial